Amikacin Dosing for E. coli Infection in Patient with Below-Knee Amputation
For a patient with E. coli infection and below-knee amputation, dose amikacin at 15 mg/kg every 24 hours based on total body weight, not adjusted body weight, as the amputation does not significantly alter volume of distribution or pharmacokinetics. 1
Standard Dosing Approach
The FDA-approved dosing for amikacin is 15 mg/kg/day divided into 2-3 equal doses (7.5 mg/kg q12h or 5 mg/kg q8h), with a maximum daily dose of 1.5 grams 1. However, once-daily dosing of 15 mg/kg is equally effective and practical for most infections 2, 3.
For urinary tract infections specifically, guidelines support 15 mg/kg once daily as an appropriate regimen 4, and recent evidence suggests this is effective even for ESBL-producing E. coli 5.
Key Dosing Considerations
Body Weight Calculation
- Use the patient's actual total body weight for dosing calculations 1
- A below-knee amputation represents approximately 5-6% of total body weight, which is not clinically significant enough to warrant dose adjustment
- The amputation does not meaningfully alter the volume of distribution (Vd) for aminoglycosides, which distribute primarily in extracellular fluid
Critical Dosing Pitfalls
Higher doses may be needed in specific circumstances:
- Patients with severe sepsis/septic shock may require ≥25 mg/kg to achieve therapeutic peaks due to increased Vd 6
- Positive fluid balance (each 250 mL increment) increases risk of subtherapeutic levels 7
- Low BMI (<25 kg/m²) paradoxically increases risk of underdosing when using total body weight 7
- Recent evidence suggests 25-30 mg/kg or even a fixed 2500 mg dose may be optimal for emergency surgery patients 8
Therapeutic Monitoring
Target concentrations:
- Peak (Cmax): >64 mg/L (measured 30-90 minutes post-infusion) 1
- Trough: <10 mg/L (ideally <2.5 mg/L at 24 hours) 1
Monitor serum levels because even with 25 mg/kg dosing, approximately 30-33% of critically ill patients fail to achieve therapeutic peaks 6, 7.
Renal Function Adjustment
If renal function is impaired:
- Extend dosing interval: Multiply serum creatinine by 9 to determine interval in hours (e.g., SCr 2 mg/dL = dose every 18 hours) 1
- OR reduce dose at fixed intervals: Adjust maintenance dose proportional to creatinine clearance reduction 1
- Always monitor drug levels in renal impairment 1
Duration and Route
- Duration: 7-10 days for most infections; 5-7 days may suffice for uncomplicated UTI 4, 1
- Route: IV infusion over 30-60 minutes 1
- For uncomplicated UTI only: 250 mg twice daily is an alternative 1
Combination Therapy Considerations
For carbapenem-resistant or ESBL-producing E. coli, amikacin is often used in combination therapy 9, 4. The combination of amikacin with fosfomycin shows synergy and prevents resistance emergence in fosfomycin-heteroresistant strains 10.
The below-knee amputation itself does not require any modification to standard amikacin dosing protocols. Focus instead on renal function, infection severity, and fluid balance status when determining the optimal dose.